rosiglitazone has been researched along with Autoimmune Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, A; Di Domenicantonio, A; Fallahi, P; Ferrari, SM; Ferri, C; Manfredi, A | 1 |
| Li, H; Pauza, CD | 1 |
| Brophy, S; Brunt, H; Davies, H; Mannan, S; Williams, R | 1 |
2 review(s) available for rosiglitazone and Autoimmune Disease
| Article | Year |
|---|---|
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines.
Topics: Animals; Autoimmune Diseases; Chemokines; Disease Models, Animal; Europe; Humans; Immunity, Cellular; Immunomodulation; Inflammation; Patents as Topic; Pioglitazone; PPAR gamma; Receptors, CXCR3; Rosiglitazone; Th1 Cells; Thiazolidinediones | 2014 |
Interventions for latent autoimmune diabetes (LADA) in adults.
Topics: Adult; Autoimmune Diseases; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
1 other study(ies) available for rosiglitazone and Autoimmune Disease
| Article | Year |
|---|---|
Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.
Topics: Animals; Autoimmune Diseases; Cell Line, Tumor; Cell Proliferation; Cytokines; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Leukocytes, Mononuclear; Ligands; Prostaglandin D2; Receptors, Antigen, T-Cell, gamma-delta; Rosiglitazone; STAT5 Transcription Factor; T-Lymphocytes; Thiazolidinediones | 2009 |